A recent whistleblower lawsuit has shed light on a long-running bribery scheme orchestrated by sales representatives from Medtronic, a prominent medical device maker, at a veterans hospital in Kansas. The lawsuit alleges that the sales reps bribed hospital staff to choose Medtronic devices over competitors’ products and to purchase an excessive amount of inventory. This scheme not only wasted millions of taxpayer dollars but also put patients’ lives at risk.
The whistleblower, Tom Schroeder, who formerly worked at a competing company called Becton Dickinson, discovered the scheme while working at the Kansas veterans hospital. He learned that Medtronic reps were bribing VA staff to purchase a large quantity of their inventory, which was then used in unnecessary medical procedures on veteran patients. Outraged by the potential harm caused to these veterans, Schroeder decided to file the lawsuit.
Medtronic, headquartered in Dublin, Ireland, is the world’s largest medical device manufacturer in terms of revenue. The company’s cardiovascular portfolio constitutes a significant portion of its sales. Schroeder’s lawsuit specifically focuses on cardiovascular devices.
The evidence presented in the lawsuit includes text messages from a Medtronic sales representative who documented the excessive use of devices in a single procedure. Instead of the typical one or two devices, a staggering 17 were used, according to the text messages. This excessive use of devices, along with other evidence, led to an internal investigation by the veterans hospital. The investigation confirmed that the hospital was purchasing an unusually high amount of inventory.
The allegations raised in the lawsuit are vehemently denied by Medtronic. The company claims that the accusations are false and asserts that it will vigorously defend itself in the litigation. Medtronic points out that Schroeder has no firsthand knowledge of any problematic procedure involving their devices.
However, past settlements involving Medtronic and its subsidiaries raise concerns. The company has paid over $60 million in settlements related to kickback schemes and fraud allegations. While Medtronic denies any wrongdoing in these settlements, it acknowledges cooperating fully with the Department of Justice and taking appropriate remedial action when necessary.
The outcome of this whistleblower lawsuit remains uncertain. Medtronic has attempted to have the case dismissed, arguing that there are insufficient factual allegations to support the claims of medically unnecessary procedures. However, the judge has allowed the allegations to proceed, recognizing the potential financial incentive for Medtronic employees to promote the use of their products. The investigation by the VA’s Office of Inspector General is still ongoing.
This lawsuit serves as a reminder of the importance of maintaining integrity in the healthcare industry and prioritizing the well-being of patients. It highlights the need for robust regulations and oversight to prevent such schemes and protect taxpayer dollars and patients’ lives.
Denial of responsibility! VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
